Olmesartan
Once-daily ARB for high blood pressure.
- Starts working
- Hours; full effect in 2–4 weeks
- Half-life
- 13 hours
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Olmesartan is an angiotensin receptor blocker for high blood pressure. It rarely causes the dry cough of ACE inhibitors and is available alone and in combinations with amlodipine and hydrochlorothiazide.
Conditions it's used for
How it works
Relaxes blood vessels by blocking angiotensin II.
Olmesartan belongs to the Angiotensin receptor blockers. How Angiotensin receptor blockers work: block the receptor angiotensin II acts on, so vessels relax and the kidneys let go of salt.
Uses
- High blood pressure
Available as: tablet, combination tablets.
Typical dose
- Adults
- 10–20 mg once a day, up to 40 mg.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Dizziness
- Headache
- Tiredness
- Back pain
Serious — get medical help
Uncommon, but need prompt attention
- High potassium
- Kidney problems
- Severe low blood pressure
- Sprue-like bowel disease (rare, with chronic use)
Warnings
- Not safe in pregnancy
- Needs blood tests for kidney function and potassium
Who should avoid it
- Pregnancy
- Severe liver failure
- Bile duct obstruction
- Diabetes with aliskiren
Interactions
- Potassium supplements and ACE inhibitors — high potassium
- NSAIDs — kidney strain
- Lithium — raised lithium levels
Other medicines in the atlas that need care with Olmesartan, grouped by the reason:
Dual blockade of the renin–angiotensin systemMajorWith Candesartan, Captopril, Enalapril, Irbesartan, Lisinopril and 6 more
Combining ACE inhibitors, ARBs or sacubitril–valsartan raises the risk of high potassium, low blood pressure and kidney injury. Sacubitril–valsartan within 36 hours of an ACE inhibitor risks dangerous swelling (angioedema).
What's usually done: Generally avoided. Leave 36 hours between an ACE inhibitor and sacubitril–valsartan.
High potassiumMajorWith Co-trimoxazole, Trimethoprim
Trimethoprim can reduce potassium excretion. Combining it with potassium supplements or potassium-raising medicines can cause dangerous hyperkalaemia.
What's usually done: Avoid where possible; check potassium and kidney function if prescribed together.
Lithium toxicityMajorWith Lithium
This medicine reduces lithium clearance by the kidneys, so levels can rise into the toxic range: vomiting, diarrhoea, coarse tremor, confusion.
What's usually done: Avoid if possible. If unavoidable, check lithium levels within a week and after any dose change.
Dangerous high potassiumMajorWith Potassium chloride
Potassium supplements with drugs that hold on to potassium can push levels high enough to disturb heart rhythm.
What's usually done: Only combine with regular blood tests; avoid potassium salt substitutes.
Kidney strain and weaker blood pressure controlModerateWith Aceclofenac, Aspirin, Celecoxib, Diclofenac, Etoricoxib and 8 more
NSAIDs reduce kidney blood flow and blunt blood pressure and diuretic effects. With both an ACE inhibitor/ARB and a diuretic ('triple whammy'), acute kidney injury is a real risk.
What's usually done: Prefer paracetamol. If an NSAID is needed, keep it short and stay hydrated; stop during vomiting or diarrhoea.
High potassium riskModerateWith Amiloride, Ciclosporin, Co-trimoxazole, Dalteparin, Enoxaparin and 6 more
Both medicines can raise potassium. Kidney disease, diabetes and older age add to the risk.
What's usually done: Commonly combined (e.g. ACE inhibitor with spironolactone in heart failure) with blood tests after starting and dose changes.
Using it safely
- Alcohol
- Best to limit. Alcohol may increase dizziness.
- Food and drink
- With or without food, at the same time each day.
- If you miss a dose
- Take when remembered; skip if nearly time for the next dose.
- Stopping it
- Don't stop without advice; blood pressure will rise.
- Driving
- Rarely causes dizziness.
- Tests and checks
- Kidney function; Potassium; Blood pressure
- If too much is taken
- Low blood pressure, fast pulse and fainting. Seek medical help.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
ARBs can harm the baby's kidneys in the second and third trimesters; stop in pregnancy.
Breastfeeding
Usually avoided
Not recommended while breastfeeding, especially in newborns.
Special groups
- Kidney disease
- Dose lowered in kidney disease; potassium monitoring needed.
- Liver disease
- Avoid in severe liver disease.
- Older adults
- Start with the lowest dose.
Brand names
- United States
- Benicar
- United Kingdom
- Olmetec
- India
- Olmezest, Olmat
- Australia
- Olmetec
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Olmesartan?
Yes — Olmesartan is prescription-only in most countries.
Can I take Olmesartan during pregnancy?
Usually avoided. ARBs can harm the baby's kidneys in the second and third trimesters; stop in pregnancy. Always check with a doctor or midwife.
How quickly does Olmesartan work?
Hours; full effect in 2–4 weeks.
Related medicines
Telmisartan
Long-acting ARB, hugely popular in India.
RxAngiotensin receptor blockersLosartan
Blood pressure medicine without the ACE-inhibitor cough.
RxWHOAngiotensin receptor blockersValsartan
ARB for blood pressure, heart failure and kidney protection.
RxAngiotensin receptor blockersAmlodipine
One of the world's most prescribed blood pressure pills.
RxWHOCalcium channel blockersCandesartan
ARB for high blood pressure and heart failure.
RxAngiotensin receptor blockersIrbesartan
ARB used for blood pressure and diabetic kidney protection.
RxAngiotensin receptor blockers
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — C09CA08
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.